Use of biological response modifiers to enhance the action of Rituximab.
Leuk Res
; 29(6): 599-600, 2005 Jun.
Article
in En
| MEDLINE
| ID: mdl-15863194
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, B-Cell
/
Immunologic Factors
/
Antibodies, Monoclonal
/
Antineoplastic Agents
Limits:
Animals
/
Humans
Language:
En
Journal:
Leuk Res
Year:
2005
Document type:
Article
Country of publication:
Reino Unido